NO993546D0 - 1,4-dihydropyridinderivater og deres anvendelse i terapi - Google Patents

1,4-dihydropyridinderivater og deres anvendelse i terapi

Info

Publication number
NO993546D0
NO993546D0 NO993546A NO993546A NO993546D0 NO 993546 D0 NO993546 D0 NO 993546D0 NO 993546 A NO993546 A NO 993546A NO 993546 A NO993546 A NO 993546A NO 993546 D0 NO993546 D0 NO 993546D0
Authority
NO
Norway
Prior art keywords
pct
therapy
dihydropyridine derivatives
date jul
sec
Prior art date
Application number
NO993546A
Other languages
English (en)
Other versions
NO993546L (no
NO315853B1 (no
Inventor
Gurard Duret
Gurard Glauert
Marguerite Henry
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of NO993546D0 publication Critical patent/NO993546D0/no
Publication of NO993546L publication Critical patent/NO993546L/no
Publication of NO315853B1 publication Critical patent/NO315853B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO19993546A 1997-01-21 1999-07-19 1,4-dihydropyridinderivater, fremgangsmåte for deres fremstilling, terapeutisk preparat samt mellomproduktforbindelser NO315853B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9700577A FR2758558B1 (fr) 1997-01-21 1997-01-21 Nouveaux derives de la 1,4-dihydropyridine et leur utilisation en therapeutique
PCT/FR1998/000042 WO1998031680A1 (fr) 1997-01-21 1998-01-12 Derives de la 1,4-dihydropyridine et leur utilisation en therapeutique

Publications (3)

Publication Number Publication Date
NO993546D0 true NO993546D0 (no) 1999-07-19
NO993546L NO993546L (no) 1999-09-21
NO315853B1 NO315853B1 (no) 2003-11-03

Family

ID=9502803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993546A NO315853B1 (no) 1997-01-21 1999-07-19 1,4-dihydropyridinderivater, fremgangsmåte for deres fremstilling, terapeutisk preparat samt mellomproduktforbindelser

Country Status (14)

Country Link
US (1) US6166035A (no)
EP (1) EP0958290B1 (no)
JP (1) JP4163260B2 (no)
AT (1) ATE221528T1 (no)
AU (1) AU727876B2 (no)
CA (1) CA2278223C (no)
DE (1) DE69806902T2 (no)
DK (1) DK0958290T3 (no)
ES (1) ES2181160T3 (no)
FR (1) FR2758558B1 (no)
NO (1) NO315853B1 (no)
NZ (1) NZ336585A (no)
PT (1) PT958290E (no)
WO (1) WO1998031680A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391881B2 (en) 2000-05-19 2002-05-21 Bristol-Myers Squibb Company Thiourea derivatives of dihydropyridine NPY antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671349B1 (fr) * 1991-01-09 1993-04-23 Lafon Labor Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant.

Also Published As

Publication number Publication date
EP0958290A1 (fr) 1999-11-24
JP2001508788A (ja) 2001-07-03
ES2181160T3 (es) 2003-02-16
JP4163260B2 (ja) 2008-10-08
NO993546L (no) 1999-09-21
WO1998031680A1 (fr) 1998-07-23
NO315853B1 (no) 2003-11-03
FR2758558B1 (fr) 1999-04-16
PT958290E (pt) 2002-11-29
DE69806902D1 (de) 2002-09-05
CA2278223C (fr) 2008-07-22
US6166035A (en) 2000-12-26
DK0958290T3 (da) 2002-12-02
NZ336585A (en) 2000-09-29
AU727876B2 (en) 2001-01-04
CA2278223A1 (fr) 1998-07-23
AU5870298A (en) 1998-08-07
EP0958290B1 (fr) 2002-07-31
DE69806902T2 (de) 2002-12-12
FR2758558A1 (fr) 1998-07-24
ATE221528T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
BR0214309A (pt) Derivados aril-1,4-pirazina substituìdos
EE03523B1 (et) Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
PT889886E (pt) Novas fenantridinas substituidas na posicao 6
DE69719778D1 (de) Benzonaphthyridine als bronchialtherapeutika
DK0950057T3 (da) 3-pyridylenantiomerer og deres anvendelse som analgetika
DE69814394D1 (de) Verwendung von levobupivacain
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
NO962477L (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
NO970573L (no) Ylidenforbindelser og deres fremstilling
ATE215525T1 (de) Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung
NO991581D0 (no) N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler
NO993546L (no) 1,4-dihydropyridinderivater og deres anvendelse i terapi
TR199901385T2 (xx) Piperidin t�revleri.
BR9808210A (pt) Befeniloxazolinas dissubstituìdas
DK1104419T3 (da) N-substituerede azabicyloheptan-derivater, deres fremstilling og anvendelse
TR200000916T2 (tr) İkameli piperidin türevleri.
ATE271878T1 (de) Verwendung von protein h als zytostattischer wirkstoff
PT937075E (pt) Novas imidazo- e oxazolo-piridinas como inibidores da fosfodiesterese

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TEVA SANTE, FR

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TEVA SANTE, FR

MK1K Patent expired